Recent results raise hope of new "broad, pan-tumor platform" like Keytruda. The emerging drugs are bispecific antibodies that ...

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the first set of abstracts have been released from several studies that will be shared at the ...

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of ...

Here are the most anticipated abstracts to keep an eye on going into the 2025 ASCO Gastrointestinal Cancers Symposium.

Revolutionary research shows statins combined with new PIN1 inhibitors could transform bladder cancer treatment, offering ...

The American Cancer Society's January 2025 report indicates that women under 50 have an 82% higher cancer incidence rate than their male counterparts. However, the report has a positive side, as ...

Health Canada has granted market authorisation to Takeda Canada for FRUZAQLA capsules to treat adults with mCRC.

Dr. Guglietta: Yes. So, it's exactly the challenge. And what we are actually seeing is that at the moment, especially for ...

Approval is based on data from the Phase III CodeBreaK 300 trial, which demonstrated that treatment with Lumakras and ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...